Accretion Nutraveda IPO 2026 – Price Band, GMP, Subscription Quota & How to Apply
Latest Grey Market Premium & IPO Details
Accretion Nutraveda IPO 2026 – Key Info & Highlights
Accretion Nutraveda SME IPO open on 28 January 2026 | Price band ₹122–₹129. Check real‑time subscription figures, GMP trends, minimum lot, quota splits, key DRHP data & company financials.
📌 IPO Details
| Company Name | Accretion Nutraveda IPO |
|---|---|
| Sector / Industry | Pharmaceuticals |
| IPO Open Date | 28-01-2026 |
| IPO Close Date | 30-01-2026 |
| Allotment Date | 02-02-2026 |
| Refund Date | 03-02-2026 |
| Share Credit Date | 03-02-2026 |
| Listing Date | 04-02-2026 |
| Price Band | ₹122 - ₹129 |
| Lot Size | 1000 Shares |
| Min Investment | ₹2,58,000 ( 2 lots Price ) |
| Total Issue Size | ₹24.77 Cr |
| Reserved for Market Maker | ₹1.24 Cr |
| Net Issue Size | ₹23.53 Cr |
| Fresh Issue | ₹23.53 Cr |
| IPO Listing At | BSE SME |
| DRHP | View DRHP |
| RHP | View RHP |
| Issue Type | Book Build Issue |
| Face Value | ₹10 Per Equity Share |
| Discount | 3000 shares (3 lots) |
| Promoter Holding Pre IPO | 100.00 % |
| Promoter Holding Post IPO | 73.48% |
| Min Small HNI Lots | 3000 shares (3 lots, ₹387000) |
* All Dates are provisional
Quota Allocation
| Category | Allocation (%) |
|---|---|
| Retail Investors | 33.33% |
| QIB (Qualified Institutional Buyers) | 47.29% |
| HNI (High Net Worth Individuals) | 14.37% |
| Reserved for Market Maker | 5% |
📈 Grey Market Premium (GMP) Day-wise Trend
| GMP Date | GMP Price | Trend | Estimated Listing Price | Estimated Profit* | Last Updated |
|---|---|---|---|---|---|
| 04-02-2026 | ₹68.00 | - | ₹197.00 | ₹68000.00 | 04-02-2026 10:00 |
| 03-02-2026 | ₹68.00 | ▲ | ₹197.00 | ₹68000.00 | 03-02-2026 23:00 |
| 02-02-2026 | ₹17.00 | ▲ | ₹146.00 | ₹17000.00 | 02-02-2026 23:56 |
📝 About Accretion Nutraveda
Accretion Nutraveda Limited is a leading Indian manufacturer of Ayurvedic and nutraceutical formulations, offering a wide range of dosage forms including tablets, capsules, syrups, powders, oils, and topical products such as balms, creams, and gels. Established in 2021, the company blends traditional Ayurvedic knowledge with modern nutraceutical research to create wellness solutions targeting key health areas such as liver support, women’s care, bone and joint health, brain function, and respiratory well-being. Operating as a Contract Development and Manufacturing Organization (CDMO), Accretion Nutraveda caters to both domestic and international markets, including Sri Lanka, Singapore, and the United States. Its diverse business verticals include domestic sales under a loan license model, which contributed over 96% of revenue in FY 2024–25, and direct exports, accounting for around 38% of revenue, reflecting steady global growth.
The company’s manufacturing facility in Gujarat spans approximately 10,763 square feet and is equipped with advanced automated machinery, 13 air handling units, dedicated processing zones, and robust quality assurance systems. Accretion Nutraveda maintains rigorous compliance and quality standards, holding certifications including GMP, WHO-GMP, FSSC 22000, ISO 9001:2015, ISO 45001:2018, Halal, and FSSAI licensing.
With a strong and experienced promoter team, a robust supply chain, and a commitment to product excellence, Accretion Nutraveda is well-positioned to capitalize on the rapidly growing wellness and nutraceutical market in India and abroad.
Accretion Nutraveda Revised Financials
Profit / Loss & Total Assets (Last 3 Years)
| Financial Year | Revenue (₹ Cr) | Profit / Loss (₹ Cr) | Total Assets (₹ Cr) |
|---|---|---|---|
| FY 2022‑23 | 2.90 | +0.28 | 4.06 |
| FY 2023‑24 | 5.01 | +0.82 | 4.64 |
| FY 2024‑25 | 16.00 | +2.61 | 10.86 |
Note: Positive figures indicate profit. Total Assets & Revenue are reported in ₹ Crores — based on company’s RHP/Prospectus data.
Accretion Nutraveda Ltd – Use of IPO Proceeds
- Automation Machinery for Existing Unit – ₹ 4.22 Cr
Funds allocated to purchase advanced automated machines for the existing manufacturing unit to enhance efficiency. - New Manufacturing Setup Machinery – ₹ 8.03 Cr
Capital expenditure for installing machinery in the new manufacturing facility to expand production capacity. - Working Capital Funding – ₹ 5.50 Cr
To support day-to-day operations, raw material procurement, and smooth business functioning. - General Corporate Purposes – Amount not specified
For administrative expenses, strategic initiatives, and overall corporate requirements.
Accretion Nutraveda Ltd – Core Strengths
- Proven Promoters and Leadership – Experienced founders and management team driving growth and innovation.
- Comprehensive Product Range – Wide portfolio of Ayurvedic and nutraceutical products catering to diverse customer needs.
- Focus on Quality Excellence – Strong commitment to manufacturing standards and product safety.
- Strong Client and Supplier Networks – Well-established relationships ensuring reliable supply chain and customer base.
- Robust Business Processes – Efficient systems and frameworks supporting operational and strategic objectives.
Accretion Nutraveda Ltd – Key Risks
- Market Volatility – Fluctuations in demand, pricing, or market trends could affect revenues and profitability.
- Regulatory and Compliance Risk – Changes in government policies, licensing requirements, or industry regulations may impact operations.
- Financial and Liquidity Risk – High borrowings or inadequate cash flows could put pressure on financial stability.
- Operational and Supply Chain Risk – Disruptions in manufacturing, logistics, or supply chain may hinder business performance.
- Competition and Market Share Risk – Intense competition or new entrants may affect growth, profitability, and market position.
Accretion Nutraveda Limited
Ayurvedic & Nutraceutical Manufacturing Company
| Founded in: | 16 March 2021 |
|---|---|
| MD/CEO: | Mr. Siddharth Shah (Founder / MD) |
| Address: | 27 Xcelon Industrial Park-1 Vasna-Chacharwadi, Ta‑Sanand Ahmedabad, Gujarat 382213, India |
| Website: | https://accretionnutraveda.com/ |
| Phone: | +91‑99043‑66177 |
| Email: | compliance@accretionnutraveda.com |
| Services: | Manufacturing of Ayurvedic, Nutraceutical & Wellness Products; Contract Development & Manufacturing Organisation (CDMO). |
IPO Quick Info
28 Jan 2026
30 Jan 2026
Upcoming
Lead Manager(s)
- Sobhagya Capital Options Pvt.Ltd.
Related IPOs
- Bagmane REIT
- Recode Studios
- OnEMI Technology
- Value 360 Communications
- Amba Auto Sales & Services
- Adisoft Technologies
- Leapfrog Engineering
- Citius Transnet InvIT
- Mehul Telecom
- Om Power Transmission
- Propshare Celestia
- Safety Controls
- Emiac Technologies
- Vivid Electromech
- Highness Microelectronics
- Sai Parenterals Limited
- Powerica Limited
- Speciality Medicines
- Tipco Engineering
- Amir Chand Jagdish Kumar
Frequently Asked Questions
The IPO offers investors an opportunity to participate in India’s growing Ayurvedic and nutraceutical sector. Funds raised will support manufacturing expansion, working capital, and general corporate purposes.